XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues, net $ 6,929 $ 8,797 $ 21,404 $ 23,986
Cost of revenues 2,745 3,511 9,137 10,527
Gross profit 4,184 5,286 12,267 13,459
Operating expenses:        
Engineering and product development 172 243 354 683
Selling and marketing 3,201 3,027 9,857 9,215
General and administrative 2,668 3,621 7,928 8,531
Settlement gains (684) 0 (684) 0
Total operating expenses 5,357 6,891 17,455 18,429
Loss from operations (1,173) (1,605) (5,188) (4,970)
Other income (expense):        
Interest expense (498) (537) (1,475) (1,592)
Interest income 49 68 344 167
Other income 0 0 0 864
Total other expense (449) (469) (1,131) (561)
Net loss $ (1,622) $ (2,074) $ (6,319) $ (5,531)
Net loss per share of common stock - basic (in Dollars per share) $ (0.36) $ (0.51) $ (1.48) $ (1.5)
Net loss per share of common stock - diluted (in Dollars per share) $ (0.36) $ (0.51) $ (1.48) $ (1.5)
Weighted average shares of common stock outstanding - basic (in Shares) 4,481,337 4,038,988 4,275,689 3,684,976
Weighted average shares of common stock outstanding - diluted (in Shares) 4,481,337 4,038,988 4,275,689 3,684,976